Reducing off-label use of antipsychotic medications may save money
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
The world.edu network focuses on education, science, innovation and the environment.
Here you can submit and vote on the best content from the world’s leading organisations and websites.
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.